Evidence map›Paper›PMID 29632147›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2018

The Synergy between Palmitate and TNF-α for CCL2 Production Is Dependent on the TRIF/IRF3 Pathway: Implications for Metabolic Inflammation.

Rasheed Ahmad, Areej Al-Roub, Shihab Kochumon, Nadeem Akther, Reeby Thomas, Manju Kumari, Merin S Koshy, Ali Tiss, Yusuf A Hannun, Jaakko Tuomilehto and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. American journal of physiology. Endocrinology and metabolism · 2023
    Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Rasheed AhmadImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait; rasheed.ahmad@dasmaninstitute.org.
Areej Al-RoubImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Shihab KochumonImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Nadeem AktherImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Reeby ThomasImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Manju KumariDivision of Endocrinology, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA 02215.
Merin S KoshyImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Ali TissProteomics Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait; and.ORCID 0000-0002-3024-5370
Yusuf A HannunStony Brook Cancer Center, Stony Brook University, Stony Brook, NY 11794.ORCID 0000-0003-3349-3369
Jaakko TuomilehtoImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Sardar SindhuImmunology Unit, Dasman Diabetes Institute, Kuwait City 15462, Kuwait.
Evan D RosenDivision of Endocrinology, Beth Israel Deaconess Medical Center, Harvard School of Medicine, Boston, MA 02215.ORCID 0000-0003-4603-708X
Dasman Diabetes Institute · KWBeth Israel Deaconess Medical Center · USStony Brook University · US

Funding

Sphingolipids in Cancer Therapy and AngiogenesisP01CA097132 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Daniel Canals · 2003 to 2026
$30.8M
Role of IRF3 in Energy and Glucose HomeostasisR01DK102170 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSEN, EVAN D · 2015 to 2024
$5.1M
Transcriptional Mechanisms of Human Insulin ResistanceR01DK102173 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSEN, EVAN D · 2015 to 2022
$4.4M
REGULATION OF NUTRIENT HOMEOSTASIS BY IRF4R01DK085171 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSEN, EVAN D · 2010 to 2018
$3.7M
Ceramide Activated Protein PhosphatasesR01CA218678 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI YUSUF AWNI HANNUN · 2018 to 2026
$3.4M
TGFbeta-mediated Transcriptional Reprogramming of Mature Adipocytes in ObesityR01DK113669 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ROSEN, EVAN D · 2017 to 2020
$2.2M
NCI NIH HHS P01 CA097132NCI NIH HHS R01 CA218678NIDDK NIH HHS R01 DK085171NIDDK NIH HHS R01 DK102170NIDDK NIH HHS R01 DK102173NIDDK NIH HHS R01 DK113669
6 · The paper itself

Abstract

The chemokine CCL2 (also known as MCP-1) is a key regulator of monocyte infiltration into adipose tissue, which plays a central role in the pathophysiology of obesity-associated inflammation and insulin resistance. It remains unclear how CCL2 production is upregulated in obese humans and rodents. Because elevated levels of the free fatty acid (FFA) palmitate and TNF-α have been reported in obesity, we studied whether these agents interact to trigger CCL2 production. Our data show that treatment of THP-1 and primary human monocytic cells with palmitate and TNF-α led to a marked increase in CCL2 production compared with either treatment alone. Mechanistically, we found that cooperative production of CCL2 by palmitate and TNF-α did not require MyD88, but it was attenuated by blocking TLR4 or TRIF. IRF3-deficient cells did not show synergistic CCL2 production in response to palmitate/TNF-α. Moreover, IRF3 activation by polyinosinic-polycytidylic acid augmented TNF-α-induced CCL2 secretion. Interestingly, elevated NF-κB/AP-1 activity resulting from palmitate/TNF-α costimulation was attenuated by TRIF/IRF3 inhibition. Diet-induced C57BL/6 obese mice with high FFAs levels showed a strong correlation between TNF-α and CCL2 in plasma and adipose tissue and, as expected, also showed increased adipose tissue macrophage accumulation compared with lean mice. Similar results were observed in the adipose tissue samples from obese humans. Overall, our findings support a model in which elevated FFAs in obesity create a milieu for TNF-α to trigger CCL2 production via the TLR4/TRIF/IRF3 signaling cascade, representing a potential contribution of FFAs to metabolic inflammation.

Indexed as

Adaptor Proteins, Vesicular TransportAdipose TissueAnimalsCell LineChemokine CCL2HumansInflammationInsulin ResistanceInterferon Regulatory Factor-3MacrophagesMiceMice, Inbred C57BLMonocytesMyeloid Differentiation Factor 88NF-kappa BPalmitatesAdaptor Proteins, Vesicular TransportChemokine CCL2Interferon Regulatory Factor-3Myeloid Differentiation Factor 88NF-kappa BPalmitatesToll-Like Receptor 4Tumor Necrosis Factor-alpha

Identifiers

PMID29632147
PMCPMC5937214
OpenAlexW2797696078

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.